Alpha 2.0
Login Register
» Authors » Roderick R Dulfer

Roderick R Dulfer

Explore the profile of Roderick R Dulfer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 44
Followers 0
Related Specialties
General Surgery
Oncology
Endocrinology
Top 10 Co-Authors
Tessa M van Ginhoven
Willemijn Y van der Plas
Schelto Kruijff
Anton F Engelsman
Liffert Vogt
Martin H de Borst
Els J M Nieveen van Dijkum
Ewout J Hoorn
Joris I Rotmans
Ezra Y Koh
Published In
Langenbecks Arch Surg
Eur J Cancer
World J Surg
Nephrol Dial Transplant
Eur J Endocrinol
Affiliations
Soon will be listed here.
Recent Articles
1.
Correction to: Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: a propensity-matched analysis
Koh E, van der Plas W, Dulfer R, Pol R, Kruijff S, Rotmans J, et al.
Langenbecks Arch Surg . 2021 Jan; 407(8):3909. PMID: 33411039
No abstract available.
2.
Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: a propensity-matched analysis
Koh E, van der Plas W, Dulfer R, Pol R, Kruijff S, Rotmans J, et al.
Langenbecks Arch Surg . 2020 Aug; 405(6):851-859. PMID: 32778916
Purpose: Calcimimetics are currently indicated for severe secondary hyperparathyroidism (SHPT). However, the role of parathyroidectomy (PTX) for these patients is still under debate, and its impact on subsequent kidney transplantation...
3.
Postoperative parathyroid hormone levels as a predictor for persistent hypoparathyroidism
Loncar I, Dulfer R, Massolt E, Timman R, de Rijke Y, Franssen G, et al.
Eur J Endocrinol . 2020 Jun; 183(2):149-159. PMID: 32580147
Objective: Hypoparathyroidism is a common complication after thyroidectomy. It is not yet possible to predict in which patients hypoparathyroidism will persist. We aim to determine whether a decrease in PTH...
4.
Timing of Parathyroidectomy Does Not Influence Renal Function After Kidney Transplantation
van der Plas W, El Moumni M, von Forstner P, Koh E, Dulfer R, van Ginhoven T, et al.
World J Surg . 2019 Feb; 43(8):1972-1980. PMID: 30798418
Background: Parathyroidectomy (PTx) is the treatment of choice for end-stage renal disease (ESRD) patients with therapy-resistant hyperparathyroidism (HPT). The optimal timing of PTx for ESRD-related HPT-before or after kidney transplantation...
5.
Changing landscape of the treatment of hyperparathyroidism related to end-stage renal disease-can we turn the clock backward?
Kruijff S, van der Plas W, Dulfer R, Vriens M, van Ginhoven T, Engelsman A, et al.
Surgery . 2018 Sep; 165(2):289-290. PMID: 30266441
No abstract available.
6.
Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review
van der Plas W, Dulfer R, Engelsman A, Vogt L, de Borst M, van Ginhoven T, et al.
Nephrol Dial Transplant . 2017 Apr; 32(11):1902-1908. PMID: 28402557
Background: Patients with end-stage renal disease (ESRD) have a decreased quality of life (QoL), which is attributable in part to ESRD-related hyperparathyroidism (HPT). Both cinacalcet and parathyroidectomy (PTx) are treatments...
7.
Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment
Kloth J, Hamberg P, Mendelaar P, Dulfer R, van der Holt B, Eechoute K, et al.
Eur J Cancer . 2016 Feb; 56:101-106. PMID: 26841094
Aim Of The Study: As a rise in mean corpuscular volume (MCV) of the erythrocyte is frequently seen during treatment with imatinib and sunitinib, we investigated whether macrocytosis (MCV > ...